Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ONC212, a fluorinated-ONC201 analogue, is a selective agonist of GPR132.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 44.00 | |
5 mg | In stock | $ 98.00 | |
10 mg | In stock | $ 162.00 | |
25 mg | In stock | $ 275.00 | |
50 mg | In stock | $ 441.00 | |
100 mg | In stock | $ 649.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 97.00 |
Description | ONC212, a fluorinated-ONC201 analogue, is a selective agonist of GPR132. |
In vitro | In vitro studies using human acute myeloid leukemia (AML) cell lines, primary AML, and normal bone marrow (BM) samples demonstrate that ONC212 exerts prominent apoptogenic effects in AML, but not in normal BM cells, suggesting potential clinical utility[1]. |
In vivo | ONC212 is active in pancreatic cancer as single agent or in combination with 5-fluorouracil, irinotecan, oxaliplatin or RTK inhibitor crizotinib. Based on upregulation of pro-survival IGF1-R in some tumors, Founded an active combination of ONC212 with inhibitor AG1024, including in vivo[2]. |
Molecular Weight | 440.46 |
Formula | C24H23F3N4O |
CAS No. | 1807861-48-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (113.52 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ONC212 1807861-48-8 Apoptosis Endocrinology/Hormones GPCR/G Protein GPR Inhibitor inhibit ONC 212 ONC-212 inhibitor